METTL3 and early-onset autosomal dominant Alzheimer disease: Huang et al. [34] demonstrated that abnormally expressed and distributed METTL3 in the hippocampus of the Alzheimer’s disease brain may be the basis for regulating gene expression changes related to disease pathogenesis.